Why can patients with diabetes develop hypoglycaemia after starting ledipasvir + sofosbuvir?

Patients with diabetes may develop symptomatic hypoglycaemia after starting ledipasvir + sofosbuvir because HCV direct-acting antiviral treatment can improve glucose control; glucose should be monitored closely, particularly during the first 3 months, and diabetes medication adjusted when necessary.